Phenylephrine Suppliers & Bulk Manufacturers
Available Forms: Injection (IV)
Available Strengths: 10 mg/mL
Reference Brands: Neo-Synephrine®, Biorphen®(US); Phenylephrine, Metaoxedrine®(EU)
Category:
Critical Care
Phenylephrine Injection is a vasopressor used to treat hypotension during anesthesia or shock. Available in 10 mg/mL strengths, it is widely used in ICUs and ORs. Top brands include Neo-Synephrine® and Biorphen®, with EU generics from Fresenius and Hameln. Ideal for critical care supply chains.
Phenylephrine is available in Injection (IV)
and strengths such as 10 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Phenylephrine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Phenylephrine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Phenylephrine Injection is a fast-acting vasopressor widely used in ICU and surgical settings to treat acute hypotension and maintain blood pressure during anesthesia. Acting as a selective alpha-1 adrenergic agonist, it induces vasoconstriction, increasing vascular resistance and elevating systolic pressure. Available in 10 mg/mL ampoules or vials, Phenylephrine must be diluted before IV administration. Trusted brands include Neo-Synephrine®, Biorphen®, and EU generics by Hameln and Fresenius. Its consistent demand in critical care, surgery, and anesthesia makes it a valuable product for hospital procurement and pharmaceutical distributors. GMP-certified and export-ready for global B2B markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing